LONDON/NEW YORK (Reuters) – London-listed drugmaker Shire Plc and Japan’s Takeda Pharmaceutical Co Ltd plan to announce a preliminary merger deal as early as Wednesday, after the latter sweetened its $62 billion acquisition offer, three people familiar with the matter said.